(177)lu-Satetraxetan-Lilotomab in the Treatment of Patients with Indolent Non-Hodgkin B-Cell Lymphoma (NHL), Phase 1/2 Safety and Efficacy Data from Four Different Pre-Dosing Regimens

Authors
Publication date
2 December 2016
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    The University of Manchester - Institutional Repository

    redirect
    oaioai:pure.atira.dk:publications...
    Last time updated on 06/08/2018